Packard A B, Roach P J, Davis R T, Carmant L, Davis R, Riviello J, Holmes G, Barnes P D, O'Tuama L A, Bjornson B, Treves S T
Division of Nuclear Medicine, Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
J Nucl Med. 1996 Jul;37(7):1101-6.
Identification of epileptogenic foci in patients with refractory epilepsy remains a significant diagnostic challenge. Magnetic resonance imaging studies frequently fail to reveal an anatomic origin for the seizures, and scalp electroencephalography is often limited to identification of the involved hemisphere. Functional imaging modalities such as PET and SPECT are more promising tools for this application because they reflect the functional pathology associated with the seizure. These changes are more pronounced ictally, but until recently, no radiopharmaceutical was available that could be used routinely for ictal SPECT. The present study was therefore undertaken to determine whether 99mTc-bicisate could be used in ictal SPECT in pediatric patients with refractory epilepsy, to compare the patterns of ictal and interictal blood flow in these patients and to compare the localization information provided by ictal SPECT with that available from other techniques.
Technetium-99m-bicisate/SPECT was compared prospectively with scalp EEG for its ability to identify a possible seizure focus in pediatric patients with refractory epilepsy. Ictal and interictal SPECT studies were performed in 10 patients (3-19 yr old, mean age 10.9 +/- 4.3 yr; 7 female, 3 male) in whom MRI scans revealed no lesions that might be responsible for the seizures.
Ictal SPECT was performed in all patients, and all ictal studies revealed focal perfusion abnormalities. By comparison, four of the interictal SPECT studies showed regional hypoperfusion that corresponded to the regions of hyperperfusion in the ictal studies, and three showed regional hyperperfusion corresponding to the hyperperfused regions in the ictal studies. Three interictal studies revealed no abnormal perfusion. Scalp EEG provided localization information in five patients.
These initial results suggest that ictal SPECT with 99mTc-bicisate is a more promising tool for the identification of epileptogenic foci than interictal SPECT or scalp EEG in patients without focal abnormalities on MRI.
确定难治性癫痫患者的致痫灶仍然是一项重大的诊断挑战。磁共振成像研究常常无法揭示癫痫发作的解剖学起源,而头皮脑电图通常仅限于确定受累的半球。正电子发射断层扫描(PET)和单光子发射计算机断层扫描(SPECT)等功能成像模式在该应用中是更有前景的工具,因为它们反映了与癫痫发作相关的功能病理学。这些变化在发作期更为明显,但直到最近,还没有可常规用于发作期SPECT的放射性药物。因此,本研究旨在确定99mTc-双半胱乙酯是否可用于难治性癫痫患儿的发作期SPECT,比较这些患者发作期和发作间期的血流模式,并将发作期SPECT提供的定位信息与其他技术提供的信息进行比较。
对99mTc-双半胱乙酯/SPECT与头皮脑电图在识别难治性癫痫患儿可能的癫痫发作灶方面的能力进行前瞻性比较。对10例患者(年龄3 - 19岁,平均年龄10.9±4.3岁;7例女性,3例男性)进行了发作期和发作间期SPECT研究,这些患者的磁共振成像扫描未发现可能导致癫痫发作的病变。
所有患者均进行了发作期SPECT检查,所有发作期研究均显示局灶性灌注异常。相比之下,4例发作间期SPECT研究显示局部灌注减低,与发作期研究中的高灌注区域相对应,3例显示局部灌注增高,与发作期研究中的高灌注区域相对应。3例发作间期研究未显示异常灌注。头皮脑电图为5例患者提供了定位信息。
这些初步结果表明,对于磁共振成像无局灶性异常的患者,99mTc-双半胱乙酯发作期SPECT在识别致痫灶方面比发作间期SPECT或头皮脑电图更有前景。